We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+15.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2B
AUM Growth
+$280M
Cap. Flow
+$118M
Cap. Flow %
5.92%
Top 10 Hldgs %
28.16%
Holding
148
New
13
Increased
87
Reduced
14
Closed
14

Top Buys

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$16.4M
2
CRUS icon
Cirrus Logic
CRUS
+$15.5M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$15.4M
4
CSIQ icon
Canadian Solar
CSIQ
+$13.8M
5
XPO icon
XPO
XPO
+$12.4M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$27.7M
2
CMRX
Chimerix, Inc.
CMRX
+$20.4M
3
SUNE
SUNEDISON, INC COM
SUNE
+$20.3M
4
TERP
TerraForm Power, Inc
TERP
+$17.7M
5
CGNX icon
Cognex
CGNX
+$7.05M

Sector Composition

Rank Sector Weight
1 Healthcare 30.11%
2 Technology 22.93%
3 Consumer Discretionary 12.85%
4 Industrials 7.77%
5 Real Estate 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.64B
$12.8M 0.64%
332,300
+5,900
+2% +$191K
XIFR
52
XPLR Infrastructure LP
XIFR
$1.12B
$12.6M 0.63%
423,750
+423,650
+423,650% +$11.1M
AY
53
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$12.6M 0.63%
655,500
+653,800
+38,459% +$11.9M
LLTC
54
DELISTED
Linear Technology Corp
LLTC
$12.4M 0.62%
292,600
– –
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$4.55B
$11.9M 0.6%
334,700
+8,000
+2% +$282K
EOG icon
56
EOG Resources
EOG
$77.5B
$10.3M 0.51%
144,800
– –
RARE icon
57
Ultragenyx Pharmaceutical
RARE
$2.56B
$9.8M 0.49%
87,400
-18,100
-17% -$1.81M
TSRO
58
DELISTED
TESARO, Inc.
TSRO
$9.42M 0.47%
180,000
+12,000
+7% +$574K
KITE
59
DELISTED
Kite Pharma, Inc.
KITE
$9.16M 0.46%
148,600
+8,600
+6% +$605K
DBVT
60
DBV Technologies
DBVT
$817M
$9.06M 0.45%
24,960
+810
+3% +$283K
AYR
61
DELISTED
Aircastle Ltd
AYR
$8.95M 0.45%
428,600
– –
LGND icon
62
Ligand Pharmaceuticals
LGND
$5.94B
$8.67M 0.43%
128,240
-53,701
-30% -$3.32M
PEGI
63
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$8.55M 0.43%
408,950
+406,900
+19,849% +$8.42M
ALNY icon
64
Alnylam Pharmaceuticals
ALNY
$27.4B
$8.47M 0.42%
90,000
+19,300
+27% +$1.79M
BMRN icon
65
BioMarin Pharmaceuticals
BMRN
$11.7B
$7.86M 0.39%
75,000
-5,400
-7% -$564K
SAGE
66
DELISTED
Sage Therapeutics
SAGE
$7.34M 0.37%
125,900
+6,700
+6% +$332K
CSLT
67
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$7.3M 0.36%
1,708,600
+925,000
+118% +$3.97M
NTUS
68
DELISTED
Natus Medical Inc
NTUS
$7.16M 0.36%
148,900
+12,900
+9% +$597K
PRTA icon
69
Prothena Corp
PRTA
$440M
$7.14M 0.36%
104,800
+17,628
+20% +$1.06M
NBIX icon
70
Neurocrine Biosciences
NBIX
$18.7B
$7.07M 0.35%
125,000
-121,100
-49% -$6.15M
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$6.8M 0.34%
150,000
+101,000
+206% +$5.29M
SUPN icon
72
Supernus Pharmaceuticals
SUPN
$2.65B
$6.69M 0.33%
498,000
+149,400
+43% +$2.31M
CLDX icon
73
Celldex Therapeutics
CLDX
$3.02B
$6.59M 0.33%
28,033
+12,780
+84% +$2.79M
CERN
74
DELISTED
Cerner Corp
CERN
$6.51M 0.33%
108,200
+6,600
+6% +$406K
BPMC
75
DELISTED
Blueprint Medicines
BPMC
$6.49M 0.32%
246,500
+139,500
+130% +$3.14M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Eventide Asset Management held 148 positions worth $2B, up 16% from $1.72B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $118M of net new capital in Q4 2015, opening 13 new positions and adding to 87 existing holdings. Its largest new stake was Cirrus Logic: 500,000 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was TerraForm Power, Inc, an estimated $17.7M trimmed.

  • Eventide Asset Management's largest Q4 2015 buy was Cirrus Logic: 500,000 shares worth $14.8M.
  • Eventide Asset Management added most to Athenahealth, Inc. in Q4 2015, an estimated $16.4M increase.
  • Eventide Asset Management's biggest Q4 2015 reduction was TerraForm Power, Inc, cutting an estimated $17.7M.
  • Eventide Asset Management fully exited DYAX CORPORATION in Q4 2015, selling an estimated $27.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $2B portfolio in Q4 2015.
  • Eventide Asset Management opened 13 new positions and closed 14 in Q4 2015.
  • Eventide Asset Management's portfolio value rose 16% quarter-over-quarter to $2B.

Based on Eventide Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.